NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options.SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech ...
News Medical on MSN20h
Exploring how 25-hydroxycholesterol triggers ferroptosis in glial cells
Oxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis.
News Medical on MSN11h
Neurofilament light as a translational biomarker from preclinical drug discovery to clinical application
Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.